Header Logo

Connection

STACEY BERG to Cyclopentanes

Back to Details
This is a "connection" page, showing publications STACEY BERG has written about Cyclopentanes.
STACEY BERG
Connection Strength
0.234
Cyclopentanes
  1. Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
    View in: PubMed
    Score: 0.234
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.